Literature DB >> 2940257

Radioimmunoassay and characterization of atrial natriuretic peptide in human plasma.

T G Yandle, E A Espiner, M G Nicholls, H Duff.   

Abstract

A RIA for alpha-human atrial natriuretic peptide (alpha hANP) in plasma was developed and used to study the immunoreactive components secreted by the heart and circulating in peripheral venous plasma. The assay used [125I]diiodotyrosyl-alpha hANP, purified by high pressure liquid chromatography (HPLC), and a C-terminal-specific antiserum purchased from Peninsula Laboratories. Serial dilution curves of coronary sinus plasma samples were parallel with the standard curve, but significant nonparallelism was found in peripheral plasma samples of low immunoreactivity. When plasma was extracted using C-18 Sep-Pak cartridges, serial dilution curves from both coronary sinus and peripheral plasma samples were parallel to the standard curve. Although values for plasma samples assayed before and after extraction agreed closely (r = 0.99; n = 76), immunoreactive ANP in unextracted plasma was consistently greater (70-79 pmol/liter) than in extracts of plasma, suggesting non-specific interference by a component in plasma when assayed without extraction. Mean plasma immunoreactive ANP in 19 normal subjects consuming a normal salt intake was 14 +/- 1 (+/- SE) pmol/liter. In 5 normal men, increasing dietary sodium intake from 10 to 200 mmol sodium/day was associated with a 2-fold increment in ANP levels, and similar changes accompanied acute sodium loading using iv saline. Elevated values were found in patients with congestive heart failure (mean, 58 pmol/liter; range, 0-200; n = 9), chronic renal failure (mean, 118 pmol/liter; range, 30-290; n = 8), and primary aldosteronism (range, 32-90 pmol/liter; n = 3). HPLC and gel chromatographic analysis of the immunoreactive material found in coronary sinus plasma extracts showed that a large amount of the material eluted in the position of alpha hANP. A smaller quantity of immunoreactive material with a mol wt of about 1600 was also identified. Peripheral venous plasma extracts also contained several immunoreactive components, the largest amount of which corresponded to alpha hANP. The pattern of immunoreactive components in peripheral venous plasma, as identified by both gel chromotography and HPLC, was similar to that in coronary sinus plasma drawn during an active phase of hormone secretion. These findings indicate that the heart secretes alpha hANP or a closely similar peptide which is also present in peripheral venous plasma. Plasma immunoreactive ANP is responsive to sodium loading in normal man and is elevated in patients with hypervolemic disorders.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2940257     DOI: 10.1210/jcem-63-1-72

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  17 in total

1.  Atrial natriuretic factor in hydrops fetalis caused by Rh isoimmunisation.

Authors:  F R Moya; P A Grannum; L Riddick; J A Robert; J Pinheiro
Journal:  Arch Dis Child       Date:  1990-07       Impact factor: 3.791

2.  Renal response to blood volume expansion in Brattleboro rats after acute treatment with vasopressin.

Authors:  R Palluk; A T Veress; H Sonnenberg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-07       Impact factor: 3.000

3.  The pharmacokinetics and pharmacodynamics of quinapril and quinaprilat in renal impairment.

Authors:  E J Begg; R A Robson; R R Bailey; K L Lynn; G J Frank; S C Olson
Journal:  Br J Clin Pharmacol       Date:  1990-08       Impact factor: 4.335

4.  Circulating levels of cardiac natriuretic peptides (ANP and BNP) measured by highly sensitive and specific immunoradiometric assays in normal subjects and in patients with different degrees of heart failure.

Authors:  A Clerico; G Iervasi; M G Del Chicca; M Emdin; S Maffei; M Nannipieri; L Sabatino; F Forini; C Manfredi; L Donato
Journal:  J Endocrinol Invest       Date:  1998-03       Impact factor: 4.256

5.  Contribution of blood and systemic circulation to the processing of pro-(atrial natriuretic factor).

Authors:  K K Murthy; G Thibault; M Cantin
Journal:  Biochem J       Date:  1988-03-15       Impact factor: 3.857

6.  Increase in plasma concentrations of cardiodilatin (amino terminal pro-atrial natriuretic peptide) in cardiac failure and during recumbency.

Authors:  L Meleagros; J S Gibbs; M A Ghatei; S R Bloom
Journal:  Br Heart J       Date:  1988-07

7.  Water and sodium disorders following surgical excision of pituitary region tumours.

Authors:  W S Poon; Y I Lolin; T F Yeung; C P Yip; K Y Goh; M K Lam; C Cockram
Journal:  Acta Neurochir (Wien)       Date:  1996       Impact factor: 2.216

8.  A double-blind randomised comparison of perindopril and ketanserin in the treatment of hypertension in elderly diabetic patients.

Authors:  J Woo; K S Woo; K H Or; C S Cockram; M G Nicholls
Journal:  Drugs Aging       Date:  1993 Nov-Dec       Impact factor: 3.923

9.  Diminished global arginine bioavailability as a metabolic defect in chronic systolic heart failure.

Authors:  W H Wilson Tang; Kevin Shrestha; Zeneng Wang; Richard W Troughton; Allan L Klein; Stanley L Hazen
Journal:  J Card Fail       Date:  2013-02       Impact factor: 5.712

10.  Brain natriuretic factor: regional plasma concentrations and correlations with haemodynamic state in cardiac disease.

Authors:  A M Richards; I G Crozier; T G Yandle; E A Espiner; H Ikram; M G Nicholls
Journal:  Br Heart J       Date:  1993-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.